Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol

NCT03022747 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lymphoblastic Leukemia, Acute, Childhood

Interventions

DRUG: Allopurinol
DRUG: Standard treatment

Sponsor

Vastra Gotaland Region